Skip to content
ppharmaranks
Menu

monistat-derm

Pharmaranks rates Monistat-Derm 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Monistat-Derm (Miconazole Nitrate) is an azole antifungal used to treat Aspergillosis, Cutaneous Candidiasis, Vulvovaginal Candidiasis, Tinea Pedis.

Miconazole Nitrate · by Insight Pharms

70/100Limited · 1 source

Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate
Verified againstopenFDANIH DailyMedRxClass
Compare online visit prices →We may earn a commission · never affects ratings

Key facts

Active ingredient
Miconazole Nitrate
Form
Topical
Strength
Miconazole Nitrate 2%
Type
Prescription (Rx)
Brand or generic
Brand-name
Manufacturer
Insight Pharms
FDA application
NDA017494
Availability
Discontinued (per FDA)

Drug class

How this class works, per Antifungal Ergosterol Synthesis Inhibitors — StatPearls, NCBI Bookshelf (NIH).

May treat (source: NIH RxClass)

See how Monistat-Derm ranks — best-rated azole antifungal for:

Dosage forms

Topical

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

What does Monistat-Derm treat?
Monistat-Derm (Miconazole Nitrate) may be used to treat aspergillosis, cutaneous candidiasis, vulvovaginal candidiasis, tinea pedis, tinea versicolor, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
How does Monistat-Derm work?
Monistat-Derm is a azole antifungal. Azole antifungals block a fungal enzyme (lanosterol 14-alpha-demethylase) that the fungus needs to make ergosterol, a key building block of its cell membrane. Without enough ergosterol the membrane becomes leaky and unstable, which stops the fungus from growing and can cause it to break apart and die.
How is Monistat-Derm rated?
pharmaranks gives Monistat-Derm a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
Is there a coupon or discount for Monistat-Derm?
pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Monistat-Derm. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Who makes Monistat-Derm?
Monistat-Derm is marketed by Insight Pharms. You can see Insight Pharms's full profile, rating, and other products on pharmaranks.
Is Monistat-Derm a brand-name or generic drug?
Monistat-Derm is a brand-name product with the active ingredient Miconazole Nitrate.
Is Monistat-Derm available over the counter?
No. Monistat-Derm is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
What forms does Monistat-Derm come in?
Monistat-Derm is currently marketed as topical, per the FDA's National Drug Code Directory.
What class of drug is Monistat-Derm?
Monistat-Derm is classified as azole antifungal, per the FDA's Established Pharmacologic Class.
Is Monistat-Derm FDA-registered?
Monistat-Derm is on record with the U.S. FDA under application number NDA017494. You can verify this on its official FDA label.
Has Monistat-Derm been recalled by the FDA?
Monistat-Derm has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
Is Monistat-Derm safe?
There's no single safe-or-not verdict. pharmaranks gives Monistat-Derm a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

What people report to the FDA about MICONAZOLE NITRATE

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 6,701 reports naming MICONAZOLE NITRATE — the active ingredient in Monistat-Derm, and the FDA flagged 49% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • vulvovaginal burning sensation1,134 reports
  • vulvovaginal pain385 reports
  • vulvovaginal pruritus332 reports
  • vulvovaginal discomfort261 reports
  • nausea201 reports
  • diarrhoea192 reports
  • international normalised ratio increased181 reports
  • rash167 reports

Read these as a signal, not a rate. A report does not mean MICONAZOLE NITRATE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved September 25, 2026.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

People also viewed

Compare Monistat-Derm head-to-head

More azole antifungal drugs

Identify a pill by its imprint →Check a drug interaction →Drug recalls →

Browse medications A–Z

Research products from A to Z, compare independent ratings, and find alternatives.